PolyPeptide Group to exhibit at CPhI Worldwide
TORRANCE, CA, USA, July 07, 2008 - The enlarged PolyPeptide Group will be exhibiting at the 2008 CPhI Worldwide Convention in Frankfurt, Germany.
We invite you to visit the enlarged PolyPeptide Group at CPhI Worldwide from September 30th – October 2nd at Messe Frankfurt GmbH. Representatives from facilities in the US and Europe will be at the PolyPeptide Group booth (Number 50F09) to meet with you and discuss any questions you may have regarding our service offerings.
PolyPeptide Group offers generic peptides, custom GMP manufacturing, custom small scale non-GMP manufacturing, as well as an extensive catalog. With the recent acquisition of NeoMPS, the enlarged group is fully capable of offering GMP manufacturing at any scale, as well as a 2nd site option for projects advancing in clinical trials.
PolyPeptide Group is a leading provider of custom and generic GMP-grade peptides for a range of pharmaceutical and biotechnology applications. With corporate roots that began in the 1950s, the Group was formally launched in 1996. Today, it operates a growing international network of peptide manufacturing facilities. Its world-class chemists and support personnel offer an unparalleled range of services for clients of every size and at every stage of product development. More information about PolyPeptide Group is available at www.PolyPeptide.com.
If you wish to schedule a meeting with our team, please contact Vivi Glaagard via e-mail at or via telephone at +45 48207000.
PolyPeptide Laboratories A/S